Corvus Pharmaceuticals Inc (CRVS) Insider Trading
- $29,934,337.75
- $35,856,130.30
- May 6, 2024
- Richard A Md Miller
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
May 6, 2024 | Insider | 20,000 | $1.73 | Buy | $34,600.00 | |
May 6, 2024 | CEO | 577,634 | $1.73 | Buy | $999,306.82 | |
May 15, 2023 | Director | 10,000 | $2.45 | Buy | $24,500.00 | |
Dec. 20, 2022 | Insider | 20,000 | $0.79 | Buy | $15,800.00 | |
Dec. 13, 2022 | CEO | 50,000 | $0.74 | Buy | $37,000.00 | |
Dec. 13, 2022 | CFO | 30,000 | $0.74 | Buy | $22,200.00 | |
Sept. 28, 2022 | CEO | 25,000 | $0.76 | Buy | $19,000.00 | |
Sept. 20, 2022 | CEO | 20,000 | $0.81 | Buy | $16,200.00 | |
June 27, 2022 | CEO | 5,000 | $1.00 | Buy | $5,000.00 | |
June 24, 2022 | CEO | 5,000 | $1.03 | Buy | $5,150.00 | |
June 6, 2022 | CEO | 890 | $1.01 | Buy | $898.90 | |
June 2, 2022 | CEO | 5,000 | $0.98 | Buy | $4,900.00 | |
March 31, 2022 | CEO | 15,000 | $1.64 | Buy | $24,600.00 | |
March 17, 2022 | CEO | 5,000 | $1.59 | Buy | $7,950.00 | |
March 16, 2022 | CFO | 35,160 | $1.54 | Buy | $54,146.40 | |
March 15, 2022 | CEO | 25,000 | $1.47 | Buy | $36,750.00 | |
Sept. 30, 2021 | Major Shareholder | 3,000,000 | $5.04 | Sell | $15,120,000.00 | |
Sept. 20, 2021 | Director | 1,109,644 | $6.09 | Sell | $6,757,731.96 | |
Aug. 20, 2021 | CEO | 10,000 | $1.93 | Buy | $19,300.00 | |
Feb. 17, 2021 | Director | 1,285,714 | $3.50 | Buy | $4,499,999.00 | |
Feb. 17, 2021 | CEO | 100,000 | $3.50 | Buy | $350,000.00 | |
July 8, 2020 | Major Shareholder | 1,538,062 | $5.31 | Sell | $8,167,109.22 | |
Nov. 12, 2019 | CEO | 272 | $2.90 | Buy | $788.80 | |
Aug. 7, 2019 | Insider | 7,500 | $3.56 | Buy | $26,700.00 | |
Aug. 6, 2019 | Director | 142,656 | $3.51 | Buy | $500,722.56 | |
July 25, 2019 | Major Shareholder | 1,400,000 | $4.00 | Sell | $5,600,000.00 | |
July 23, 2019 | Major Shareholder | 39,716 | $5.32 | Sell | $211,289.12 | |
July 1, 2019 | Director | 657,344 | $3.72 | Buy | $2,445,319.68 | |
June 27, 2019 | Director | 32,923 | $3.34 | Buy | $109,962.82 | |
June 13, 2019 | CEO | 343 | $3.52 | Buy | $1,207.36 | |
June 11, 2019 | Insider | 15,212 | $3.49 | Buy | $53,089.88 | |
June 7, 2019 | CEO | 9,212 | $3.37 | Buy | $31,044.44 | |
June 6, 2019 | CFO | 15,500 | $3.56 | Buy | $55,180.00 | |
Dec. 27, 2018 | CEO | 20,000 | $3.29 | Buy | $65,800.00 | |
Dec. 27, 2018 | Insider | 20,000 | $3.29 | Buy | $65,800.00 | |
Dec. 21, 2018 | CFO | 24,700 | $4.15 | Buy | $102,505.00 | |
Dec. 20, 2018 | CEO | 10,000 | $4.40 | Buy | $44,000.00 | |
Dec. 6, 2018 | CEO | 5,000 | $5.99 | Buy | $29,950.00 | |
Dec. 4, 2018 | CEO | 1,502 | $5.95 | Buy | $8,936.90 | |
March 12, 2018 | CEO | 100,000 | $8.50 | Buy | $850,000.00 | |
March 12, 2018 | Major Shareholder | 588,235 | $8.50 | Buy | $4,999,997.50 | |
Nov. 20, 2017 | CEO | 10,000 | $10.79 | Buy | $107,900.00 | |
June 23, 2017 | Major Shareholder | 20,000 | $10.95 | Buy | $219,000.00 | |
June 13, 2017 | Insider | 25,000 | $9.88 | Buy | $247,000.00 | |
June 24, 2016 | Director | 1,000 | $12.98 | Buy | $12,980.00 | |
June 21, 2016 | Director | 38,383 | $12.75 | Buy | $489,383.25 | |
June 16, 2016 | Director | 20,000 | $12.35 | Buy | $247,000.00 | |
June 10, 2016 | Director | 50,000 | $12.96 | Buy | $648,000.00 | |
May 20, 2016 | Director | 4,716 | $13.09 | Buy | $61,732.44 | |
May 19, 2016 | Director | 6,800 | $11.77 | Buy | $80,036.00 |
Insiders are both buying and selling Corvus Pharmaceuticals Inc stock.
The insider traders at Corvus Pharmaceuticals Inc are: Richard A Md Miller, Orbimed Advisors Llc, Peter A Thompson, Holdings A/S Novo, Leiv Lea, Adams Street Partners Llc, William Benton Jones, Ecor1 Capital, Llc, A/S Novo, and Linda Grais
The most active insider trader at Corvus Pharmaceuticals Inc is Richard A Md Miller with 27 trades.
Ecor1 Capital, Llc has sold the most Corvus Pharmaceuticals Inc stock with a total value of $30,240,000.00.
Adams Street Partners Llc has bought the most Corvus Pharmaceuticals Inc stock with a total value of $12,999,995.00.
The most recent insider trade for Corvus Pharmaceuticals Inc was on May 6, 2024.
The single biggest insider buy for Corvus Pharmaceuticals Inc was from Peter A Thompson with a total value of $8,250,000.00 on March 29, 2016.
The single biggest insider sell for Corvus Pharmaceuticals Inc was from Ecor1 Capital, Llc with a total value of $15,120,000.00 on Sept. 30, 2021.